Erratum : Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB 1 content of axon terminals (Nature Communications (2015) 6:6557 doi: 10.1038/ncomms7557);Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals

Nature Communications

Volumn 6, Issue , 2015, Pages

  Lenkey, Nora ^a   Kirizs, Tekla ^a,b   Holderith, Noemi ^a   Máté, Zoltán ^a   Szabó, Gábor ^a   Vizi, E Sylvester ^a   Hájos, Norbert ^a   Nusser, Zoltan ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CHOLECYSTOKININ; ENDOCANNABINOID; PARVALBUMIN; VESICULAR INHIBITORY AMINO ACID TRANSPORTER; 4 AMINOBUTYRIC ACID; CALCIUM; PHOTOPROTEIN; RED FLUORESCENT PROTEIN;

CELL ORGANELLE; HYPOTHESIS TESTING; IMMUNE RESPONSE; NERVOUS SYSTEM; NEUROLOGY; PROTEIN;

4 AMINOBUTYRIC ACID RELEASE; ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; DENTATE GYRUS; FEMALE; IMMUNOGOLD LABELING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; MICROSCOPY; MOUSE; NERVE ENDING; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; STRATUM PYRAMIDALE; ANIMAL; CLASSIFICATION; CYTOLOGY; GENETICS; HIPPOCAMPUS; METABOLISM; NERVE CELL; NEWBORN; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; CALCIUM; ENDOCANNABINOIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; LUMINESCENT PROTEINS; MALE; MICE; MICE, TRANSGENIC; NEURONS; PRESYNAPTIC TERMINALS; RECEPTOR, CANNABINOID, CB1;

EID: 84928141323     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9226     Document Type: Erratum

References (51)

1. Nusser, Z. et al. Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus. Neuron 21, 545-559 (1998).
2. Nicholson, D. A. et al. Distance-dependent differences in synapse number and AMPA receptor expression in hippocampal CA1 pyramidal neurons. Neuron 50, 431-442 (2006).
3. Tanaka, J. et al. Number and density of AMPA receptors in single synapses in immature cerebellum. J. Neurosci. 25, 799-807 (2005).
4. Tarusawa, E. et al. Input-specific intrasynaptic arrangements of ionotropic glutamate receptors and their impact on postsynaptic responses. J. Neurosci. 29, 12896-12908 (2009).
5. Budisantoso, T. et al. Evaluation of glutamate concentration transient in the synaptic cleft of the rat calyx of Held. J. Physiol. 591, 219-239 (2013).
6. Momiyama, A. et al. The density of AMPA receptors activated by a transmitter quantum at the climbing fibre-Purkinje cell synapse in immature rats. J. Physiol. 549, 75-92 (2003).
7. Nusser, Z., Cull-Candy, S. & Farrant, M. Differences in synaptic GABA(A) receptor number underlie variation in GABA mini amplitude. Neuron 19, 697-709 (1997).
8. Nusser, Z., Hajos, N., Somogyi, P. & Mody, I. Increased number of synaptic GABA(A) receptors underlies potentiation at hippocampal inhibitory synapses. Nature 395, 172-177 (1998).
9. Bjarnadottir, T. K. et al. Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics 88, 263-273 (2006).
10. Paton, W. D. & Vizi, E. S. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br. J. Pharmacol. 35, 10-28 (1969).
11. Miller, R. J. Presynaptic receptors. Ann. Rev. Pharmacol. Toxicol. 38, 201-227 (1998).
12. Kreitzer, A. C. & Regehr, W. G. Retrograde signaling by endocannabinoids. Curr. Opin. Neurobiol. 12, 324-330 (2002).
13. Freund, T. F., Katona, I. & Piomelli, D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 1017-1066 (2003).
14. Wilson, R. I. & Nicoll, R. A. Endocannabinoid signaling in the brain. Science 296, 678-682 (2002).
15. Meir, A. et al. Ion channels in presynaptic nerve terminals and control of transmitter release. Physiol. Rev. 79, 1019-1088 (1999).
16. Sudhof, T. C. The synaptic vesicle cycle. Annu. Rev. Neurosci. 27, 509-547 (2004).
17. de Jong, A. P. & Verhage, M. Presynaptic signal transduction pathways that modulate synaptic transmission. Curr. Opin. Neurobiol. 19, 245-253 (2009).
18. Szabo, G. G. et al. Presynaptic calcium channel inhibition underlies CB1 cannabinoid receptor-mediated suppression of GABA release. J. Neurosci. 34, 7958-7963 (2014).
19. Katona, I. et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19, 4544-4558 (1999).
20. Losonczy, A., Biro, A. A. & Nusser, Z. Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc. Natl Acad. Sci. USA 101, 1362-1367 (2004).
21. Lee, S. H., Foldy, C. & Soltesz, I. Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus. J. Neurosci. 30, 7993-8000 (2010).
22. Ali, A. B. CB1 modulation of temporally distinct synaptic facilitation among local circuit interneurons mediated by N-type calcium channels in CA1. J. Neurophysiol. 105, 1051-1062 (2011).
23. Zhang, W. & Linden, D. J. Neuromodulation at single presynaptic boutons of cerebellar parallel fibers is determined by bouton size and basal action potential-evoked Ca transient amplitude. J. Neurosci. 29, 15586-15594 (2009).
24. Nyiri, G., Cserep, C., Szabadits, E., Mackie, K. & Freund, T. F. CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience 136, 811-822 (2005).
25. Dudok, B. et al. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nat. Neurosci. 18, 75-86 (2015).
26. Holderith, N. et al. Release probability of hippocampal glutamatergic terminals scales with the size of the active zone. Nat. Neurosci. 15, 988-997 (2012).
27. Vida, I. & Frotscher, M. A hippocampal interneuron associated with the mossy fiber system. Proc. Natl Acad. Sci. USA 97, 1275-1280 (2000).
28. Klausberger, T. et al. Complementary roles of cholecystokinin-And parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J. Neurosci. 25, 9782-9793 (2005).
29. Lasztoczi, B., Tukker, J. J., Somogyi, P. & Klausberger, T. Terminal field and firing selectivity of cholecystokinin-expressing interneurons in the hippocampal CA3 area. J. Neurosci. 31, 18073-18093 (2011).
30. Pawelzik, H., Hughes, D. I. & Thomson, A. M. Physiological and morphological diversity of immunocytochemically defined parvalbumin-And cholecystokininpositive interneurones in CA1 of the adult rat hippocampus. J. Comp. Neurol. 443, 346-367 (2002).
31. Szabo, G. G., Papp, O. I., Mate, Z., Szabo, G. & Hajos, N. Anatomically heterogeneous populations of CB1 cannabinoid receptor-expressing interneurons in the CA3 region of the hippocampus show homogeneous inputoutput characteristics. Hippocampus 24, 1506-1523 (2014).
32. Mate, Z. et al. Spatiotemporal expression pattern of DsRedT3/CCK gene construct during postnatal development of myenteric plexus in transgenic mice. Cell Tissue Res. 352, 199-206 (2013).
33. Kim, J., Isokawa, M., Ledent, C. & Alger, B. E. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J. Neurosci. 22, 10182-10191 (2002).
34. Masugi-Tokita, M. & Shigemoto, R. High-resolution quantitative visualization of glutamate and GABA receptors at central synapses. Curr. Opin. Neurobiol. 17, 387-393 (2007).
35. Lee, S. H. et al. Parvalbumin-positive basket cells differentiate among hippocampal pyramidal cells. Neuron 82, 1129-1144 (2014).
36. Kisfali, M., Lrincz, T. & Vizi, E. S. Comparison of Ca2+ transients and [Ca2+]i in the dendrites and boutons of non-fast-spiking GABAergic hippocampal interneurons using two-photon laser microscopy and high-And low-Affinity dyes. J. Physiol. 591, 5541-5553 (2013).
37. Gulyas, A. I. & Freund, T. F. Pyramidal cell dendrites are the primary targets of calbindin D28k-immunoreactive interneurons in the hippocampus. Hippocampus 6, 525-534 (1996).
38. Kim, J. & Alger, B. E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat. Neurosci. 7, 697-698 (2004).
39. Maccarrone, M. et al. Anandamide inhibits metabolism and physiological actions of 2-Arachidonoylglycerol in the striatum. Nat. Neurosci. 11, 152-159 (2008).
40. Katona, I. & Freund, T. F. Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 35, 529-558 (2012).
41. Katona, I. et al. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 26, 5628-5637 (2006).
42. Gulyas, A. I. et al. Segregation of two endocannabinoid-hydrolyzing enzymes into pre-And postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur. J. Neurosci. 20, 441-458 (2004).
43. Walter, L., Dinh, T. & Stella, N. ATP induces a rapid and pronounced increase in 2-Arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. J. Neurosci. 24, 8068-8074 (2004).
44. de Vivo, L., Melone, M., Rothstein, J. D. & Conti, F. GLT-1 promoter activity in astrocytes and neurons of mouse hippocampus and somatic sensory cortex. Front. Neuroanat. 3, 31 (2010).
45. Nyilas, R. et al. Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. J. Neurosci. 28, 1058-1063 (2008).
46. Mikasova, L., Groc, L., Choquet, D. & Manzoni, O. J. Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization. Proc. Natl Acad. Sci. USA 105, 18596-18601 (2008).
47. Fukudome, Y. et al. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur. J. Neurosci. 19, 2682-2692 (2004).
48. Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. & Bonner, T. I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl Acad. Sci. USA 96, 5780-5785 (1999).
49. Ino, M. et al. Functional disorders of the sympathetic nervous system in mice lacking the alpha 1B subunit (Cav 2.2) of N-type calcium channels. Proc. Natl Acad. Sci. USA 98, 5323-5328 (2001).
50. Kirizs, T., Kerti-Szigeti, K., Lorincz, A. & Nusser, Z. Distinct axo-somatodendritic distributions of three potassium channels in CA1 hippocampal pyramidal cells. Eur. J. Neurosci. 39, 1771-1783 (2014).
51. Kerti, K., Lorincz, A. & Nusser, Z. Unique somato-dendritic distribution pattern of Kv4.2 channels on hippocampal CA1 pyramidal cells. Eur. J. Neurosci. 35, 66-75 (2012).